Clinical Evaluation of LifeScan Blood Glucose Monitoring Systems
NCT ID: NCT03920085
Last Updated: 2020-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
123 participants
INTERVENTIONAL
2019-01-08
2019-02-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical System Accuracy Evaluation With OneTouch® Verio Flex Blood Glucose Monitoring System (BGMS)
NCT03085251
Assessment of Blood Glucose Monitoring Devices With New Insight Features
NCT02929654
Customer Outcomes & Value Experiencing A New Monitoring Technology
NCT04262700
Clinical Benefits of a Blood Glucose Monitoring System in Patients With Type 2 Diabetes
NCT00401622
Comparison Evaluation of Blood Glucose Meter Systems
NCT01548885
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LifeScan BGMSs
OneTouch Verio, OneTouch Select Plus and OneTouch Ultra Blood Glucose Monitoring Systems (BGMSs) tested using subject capillary blood and compared to a reference instrument (YSI 2900).
OneTouch Verio
OneTouch Verio Blood Glucose Monitoring System.
OneTouch Select Plus
OneTouch Select Plus Blood Glucose Monitoring System.
OneTouch Ultra
OneTouch Ultra Blood Glucose Monitoring System.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OneTouch Verio
OneTouch Verio Blood Glucose Monitoring System.
OneTouch Select Plus
OneTouch Select Plus Blood Glucose Monitoring System.
OneTouch Ultra
OneTouch Ultra Blood Glucose Monitoring System.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants must have read the Information sheet and signed an informedconsent form \>prior to study participation.
* Participants must be 16 years or older.
* Participants must be diagnosed with Diabetes
Exclusion Criteria
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MAC Clinical Research
OTHER
LifeScan Scotland Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MAC Clinical Research
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3177234
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.